Lunaphore at the Advancing Biomarkers Analysis Europe Online Conference
Join us at the Advancing Biomarkers Analysis Europe Online Conference and follow our exclusive presentation and roundtable discussion.
Spatial Biomarkers 2.0: The Next Steps of Immunotherapy
Date: 14 September 2021, 15:30 – 16:00 UTC+1
– Next generation of biomarker evaluation: from IHC to multiplexed IF
– Advantages of multiplexed IF from basic to clinical research
Prof. Dr. MD Paolo Ascierto – Director of the Department of Melanoma, Cancer Immunotherapy and Development Therapeutics Institution: National Tumor Institute – Naples, Italy. Dr. Ascierto is a member of the Steering Committee of Society of Melanoma Research (SMR) and the Board of Directors of Society of ImmunoTherapy of Cancer (SITC).
Dr. MD Carlo Bifulco – Director of Molecular Pathology and Pathology Informatics at Providence and Director of Translational Molecular Pathology and Molecular Genomics at the Earle A. Chiles Research Institute. Dr. Bifulco serves on the Global Colon Cancer Immunoscore Task Force led by the Society for Immunotherapy of Cancer (SITC) and is co-Chair of the SITC Pathology Task convened to establish multiplexed immunohistochemistry/immunofluorescence (mIHC/IF) standards.
How to optimize a hyper-plex immunostaining panel in a fast and robust manner
Date: 14 September 2021, 13:30 – 13:50 UTC+1
Speaker: Dr. Saska Brajkovic, Head of Application Development, Lunaphore
Abstract: Multiplexed immunofluorescence is a technique which can provide unparalleled insight into biomarker expression-based analyses in tissue, including studying the interaction of different cell types in the tumor microenvironment using a single tissue section. One of the challenging aspects related to this technique is the optimization of new markers and building marker panels of interest. Here, we present a fast, robust and automated method for optimizing hyper-plex panels using the COMET™ technology.